Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Emphysema: 2018 Pipeline Insights - Features Abeona Therapeutics, Angion Biomedica, ProMetic Life Sciences, and rEVO Biologics - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Oct 18

The "Emphysema - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Emphysema development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Scope

  • The report provides a snapshot of the pipeline development for Emphysema
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Emphysema
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Emphysema
  • The report also covers the dormant and discontinued pipeline projects related to Emphysema
Companies Featured
  • Abeona Therapeutics
  • Angion Biomedica Corp.
  • ProMetic Life Sciences Inc.
  • rEVO Biologics

Key Topics Covered

1. Report Introduction

2. Emphysema Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Emphysema

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/kp79dc/emphysema_2018?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005361/en/

Business Wire
www.businesswire.com

Last updated on: 19/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.